Preventive effects of Hangeshashinto for oral mucositis in Hematopoietic Stem Cell Transplantation Recipients
Phase 2
- Conditions
- Patients who will undergo allogeneic hematopoietic stem cell transplantation
- Registration Number
- JPRN-jRCTs071200012
- Lead Sponsor
- Yoshimatsu Masako
- Brief Summary
Hangeshashinto was recognized tendency to have potential inhibition of oral mucositis exacerbation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients who will undergo allogeneic hematopoietic stem cell transplantation
Exclusion Criteria
Patients with problem in judgement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and onset timing of grade 2 oral mucositis
- Secondary Outcome Measures
Name Time Method Incidence and onset timing of grade 1,3,4 and 5 oral mucositis